US4200652A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Alkanolamine derivatives
Assignee: Imperial Chemical Industries Ltd
•
Filing: 1978-08-02
•
Granted: 1980-04-29
•
Expires: 1998-08-02
Abstract
Abstract Novel 1-aryloxy-3-carbamoylalkylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess beta -adrenergic blocking activity. Representative of the compounds disclosed is 1-(2-cyanophenoxy)-3- beta -(N-2-furfurylcarbamoyl)ethylamino-2-propanol.
Inventors
- 👤 Michael S. Large
- 👤 Leslie H. Smith
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 22:55
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/36; C07D213/40; C07D307/00; C07D307/02; C07D307/34; C07D307/38; C07D307/52; C07D307/77; C07D307/78; C07D307/79; C07D309/00; C07D309/02; C07D309/04; C07D319/00; C07D319/10; C07D319/14; C07D319/16; C07D319/18; C07D333/00; C07D333/50; C07D333/52; C07D333/54
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
196 words
An alkanolamine derivative selected from the group consisting of a compound of the formula: R--OCH.sub.2.CHOH.CH.sub.2 NH--A--CO--NH--Y--R.sup.1 wherein A is alkylene of 2 to 12 carbon atoms; wherein Y is a direct link, or alkylene of up to 6 carbon atoms or alkyleneoxy of from 2 to 6 carbon atoms; and wherein R is aryl of the formula: ##STR13## and R 1 is aryl of the formula: ##STR14## or cycloalkyl of up to 10 carbon atoms; wherein R 2 , R 3 , R 12 and R 13 , which may be the same or different, each is hydrogen, halogen, hydroxy, amino, nitro, or cyano, alkyl, hydroxyalkyl, cycloalkyl, alkenyl, alkynyl, alkoxy, alkylthio, cycloalkoxy, alkenyloxy, alkynyloxy or alkanoyl each of up to 6 carbon atoms, or aryl, aryloxy or dialkylamino each of up to 12 carbon atoms; or wherein R 2 and R 3 together, and/or R 12 and R 13 together, form trimethylene, tetramethylene, 1-oxotetramethylene, propenylene, but-2-enylene or buta-1,3-dienylene such that together with the adjacent benzene ring they form respectively indanyl, 5,6,7,8-tetrahydronaphthyl, 5-oxo-5,6,7,8-tetrahydronaphthyl, indenyl, 5,8-dihydronaphthyl or naphthyl; provided that A separates imino and carbonyl by at least 2 carbon atoms; and a non-toxic pharmaceutically-acceptable acid-addition salt thereof.
Claim 2
Dependent Claim
196 words
An alkanolamine derivative selected from the group consisting of a compound of the formula: R--OCH.sub.2.CHOH.CH.sub.2 NH--A--CO--NH--Y--R.sup.1 wherein A is alkylene of 2 to 12 carbon atoms; wherein Y is a direct link, or alkylene of up to 6 carbon atoms or alkyleneoxy of from 2 to 6 carbon atoms; and wherein R is aryl of the formula: ##STR13## and R 1 is aryl of the formula: ##STR14## or cycloalkyl of up to 10 carbon atoms; wherein R 2 , R 3 , R 12 and R 13 , which may be the same or different, each is hydrogen, halogen, hydroxy, amino, nitro, or cyano, alkyl, hydroxyalkyl, cycloalkyl, alkenyl, alkynyl, alkoxy, alkylthio, cycloalkoxy, alkenyloxy, alkynyloxy or alkanoyl each of up to 6 carbon atoms, or aryl, aryloxy or dialkylamino each of up to 12 carbon atoms; or wherein R 2 and R 3 together, and/or R 12 and R 13 together, form trimethylene, tetramethylene, 1-oxotetramethylene, propenylene, but-2-enylene or buta-1,3-dienylene such that together with the adjacent benzene ring they form respectively indanyl, 5,6,7,8-tetrahydronaphthyl, 5-oxo-5,6,7,8-tetrahydronaphthyl, indenyl, 5,8-dihydronaphthyl or naphthyl; provided that A separates imino and carbonyl by at least 2 carbon atoms; and a non-toxic pharmaceutically-acceptable acid-addition salt thereof.
Claim 3
Dependent Claim
115 words
An alkanolamine derivative as claimed in claim 1 selected from the group consisting of a compound of the formula given in claim 1 wherein A is ethylene, trimethylene, 1-methylethylene or 1,1-dimethylethylene; wherein R is phenyl, R 2 is in the 2-position of the phenyl nucleus and is hydrogen, chloro, cyano or alkyl or alkoxy of up to 3 carbon atoms, and R 3 is hydrogen, or R is unsubstituted naphthyl; wherein R 1 is cycloalkyl each of up to 6 carbon atoms, or unsubstituted phenyl; and wherein Y is a direct link, or alkylene of up to 3 carbon atoms or alkyleneoxy of 2 to 4 carbon atoms; and a non-toxic, pharmaceutically-acceptable acid-addition salt thereof.
Claim 4
Dependent Claim
63 words
An alkanolamine derivative as claimed in claim 2 wherein A is ethylene, R is phenyl, R 2 is in the 2-position of the phenyl nucleus and is hydrogen, chloro or cyano, or alkyl or alkoxy each of up to 3 carbon atoms, and R 3 is hydrogen; R 1 is unsubstituted phenyl, and Y is methylene, or a non-toxic pharmaceutically-acceptable acid-addition salt thereof.
Claim 5
Dependent Claim
34 words
An acid-addition salt as claimed in claim 1 which is hydrochloride, hydrobromide, phosphate, sulphate, oxalate, lactate, tartrate, acetate, salicylate, citrate, benzoate, β-naphthoate, adipate or 1,1-methylene-bis-(2-hydroxy-3-naphthoate), or a salt derived from a sulphonated polystyrene resin.
Claim 6
Dependent Claim
30 words
A pharmaceutical composition comprising as active ingredient at least one alkanolamine derivative or an acid-addition salt thereof, claimed in claim 1, in association with a pharmaceutically-acceptable diluent or carrier therefor.
Claim 7
Dependent Claim
34 words
A method for the treatment or prophylaxis of heart diseases and hypertension in a warm-blooded animal which comprises administering to said animal an effective amount of at least one compound claimed in claim 1.
Claim 8
Dependent Claim
34 words
A method for producing coronary β-adrenergic blockade in a warm-blooded animal in need of such blockade which comprises administering to said animal an effective amount of at least one compound claimed in claim 1.
Claim 9
Dependent Claim
9 words
The compound 1-phenoxy-3-β-(N-benzylcarbamoyl) ethylamino-2-propanol or an acid-addition salt thereof.
Claim 10
Dependent Claim
9 words
The compound 1-phenoxy-3-β-(N-benzylcarbamoyl) ethylamino-2-propanol or an acid-addition salt thereof.
References Cited (Backward Citations)
US3663607A
Cited
US3793365A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-04-29 | 1983-10-29 | 1984-04-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-04-29 | 1987-10-29 | 1988-04-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-04-29 | 1991-10-29 | 1992-04-29 | $7700.00 | Window Closed / Lapsed |